Cargando…

Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.

We examined the effect of selective thromboxane A2 (TXA2) receptor antagonists, calcium 5(Z)-1R, 2S, 3S, 4S-7-[3-phenylsulphonylaminobicyclo [2.2.1] hept-2-yl]-5-heptonoate hydrate (S-1452) and +/- -7-(3,5,6,-trimethyl-1,4-benzoquinon-2-yl)-7-phenylhaptanoic acid (AA-2414), on sensitivity to cis-dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasahara, K., Fujimura, M., Bando, T., Shibata, K., Shirasaki, H., Matsuda, T.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074842/ https://www.ncbi.nlm.nih.gov/pubmed/8932334

Ejemplares similares

Characterization of Acquired Resistance to cis‐Diamminedichloroplatinum(II) in Mouse Leukemia Cell Lines
por: Tashiro, Tazuko, et al.
Publicado: (1992)

Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.
por: Sugimoto, Y., et al.
Publicado: (1992)

Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
por: Timmer-Bosscha, H., et al.
Publicado: (1992)

Interaction of cis-diamminedichloroplatinum(II) with phi X174 DNA.
por: Zahoor, A., et al.
Publicado: (1986)

Effect of diethyldithiocarbamate on toxicity of doxorubicin, cyclophosphamide and cis-diamminedichloroplatinum (II) on mice haemopoietic progenitor cells.
por: Pannacciulli, I. M., et al.
Publicado: (1989)

Interactions of radiation and adriamycin, bleomycin, mitomycin C or cis-diamminedichloroplatinum II in intestinal crypt cells.
por: von der Maase, H.
Publicado: (1984)

Lentinan Enhances Sensitivity of Mouse Colon 26 Tumor to cis‐Diamminedichloroplatinum(II) and Decreases Glutathione Transferase Expression
por: Murata, Tetsuo, et al.
Publicado: (1996)

Hyperthermic Enhancement of Cytotoxicity and Increased Uptake of cis‐Diamminedichloroplatinum(II) in Cultured Human Esophageal Cancer Cells
por: Miyahara, Tokiharu, et al.
Publicado: (1993)

Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models.
por: Poirier, M C, et al.
Publicado: (1985)

Establishment and Characterization of Non‐small Cell Lung Cancer Cell Lines Resistant to Mitomycin C under Aerobic Conditions
por: Shibata, Kazuhiko, et al.
Publicado: (1995)

A Human Head and Neck Squamous Cell Carcinoma Cell Line with Acquired cis-Diamminedichloroplatinum-Resistance Shows Remarkable Upregulation of BRCA1 and Hypersensitivity to Taxane
por: Saiki, Yuriko, et al.
Publicado: (2011)

The Inhibitory Effect of the Combination of Antineoplaston A‐10 Injection with a Small Dose of cis‐Diamminedichloroplatinum on Cell and Tumor Growth of Human Hepatocellular Carcinoma
por: Tsuda, Hideaki, et al.
Publicado: (1992)

A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report
por: Matsuno, Yoritaka, et al.
Publicado: (2012)

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
por: Kumar, Smriti, et al.
Publicado: (2011)

Thromboxane Mobilizes Insect Blood Cells to Infection Foci
por: Roy, Miltan Chandra, et al.
Publicado: (2021)

Thromboxane Modulates Endothelial Permeability
por: Klausner, J. M., et al.
Publicado: (1994)

Stability of thromboxane in blood samples
por: Helgadóttir, Helga, et al.
Publicado: (2019)

NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension
por: Mulvaney, Eamon P., et al.
Publicado: (2020)

Measurement of Thromboxane Biosynthesis in Health and Disease
por: Patrono, Carlo, et al.
Publicado: (2019)

Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy
por: Obilade, Opeyemi Abayomi, et al.
Publicado: (2017)

Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells
por: Dagher, Oula K., et al.
Publicado: (2019)

Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer
por: Watkins, Gareth, et al.
Publicado: (2005)

Foetal vascular responses to thromboxane receptor blockade
por: Meyer, B. A., et al.
Publicado: (1992)

Prostacyclin and thromboxane in benign and malignant breast tumours.
por: Laekeman, G. M., et al.
Publicado: (1986)

Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats
por: Lagier, David, et al.
Publicado: (2019)

The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload
por: Mulvaney, Eamon P., et al.
Publicado: (2022)

ADP and Thromboxane Inhibitors Both Reduce Global Contraction of Clot Length, While Thromboxane Inhibition Attenuates Internal Aggregate Contraction
por: Trigani, Kevin T., et al.
Publicado: (2022)

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer
por: Cathcart, Mary-Clare, et al.
Publicado: (2011)

An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis
por: Pal, Saumen, et al.
Publicado: (2006)

Influence of Thromboxane A(2) on the Regulation of Adenosine Triphosphate-Sensitive Potassium Channels in Mouse Ventricular Myocytes
por: Jeong, In Seok, et al.
Publicado: (2016)

Thromboxane generation by human peripheral blood polymorphonuclear leukocytes
Publicado: (1978)

Thromboxane generation by human monocytes enhances platelet function
Publicado: (1986)

Platelet Dysfunction in Type 1 Diabetes: Stressing the Thromboxanes
por: Wisinski, Jaclyn A., et al.
Publicado: (2016)

The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review
por: Szczuko, Małgorzata, et al.
Publicado: (2021)

Differential and antagonistic effects of 9- cis -retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro
por: Pettersson, F, et al.
Publicado: (2000)

18β-Glycyrrhetinic Acid Suppresses Cell Proliferation through Inhibiting Thromboxane Synthase in Non-Small Cell Lung Cancer
por: Huang, Run-Yue, et al.
Publicado: (2014)

Synthesis, Stability, and Biological Studies of Fluorinated Analogues of Thromboxane A(2)
por: Jing, Changcheng, et al.
Publicado: (2020)

Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury
por: Yan, Aijuan, et al.
Publicado: (2016)

Thromboxane A(2) receptor antagonist (ONO‐8809) attenuates renal disorders caused by salt overload in stroke‐prone spontaneously hypertensive rats
por: Nagatani, Yusuke, et al.
Publicado: (2021)

Urinary 11‐Dehydro‐Thromboxane B(2) as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
por: Szczeklik, Wojciech, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tdmrbum0g6v52oui9v8mnrh9oq